A Pivotal Shift in the Field
In recent years, the landscape of obesity management has undergone a significant transformation — and nowhere was this more evident than at the combined annual world conference of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) and the Australian and New Zealand Metabolic and Obesity Surgery Society (ANZMOSS), held in Melbourne in September 2024.
This gathering of well over 1,000 professionals from various disciplines marked a pivotal shift in the approach to treating obesity and metabolic diseases. Historically, these conferences have focused heavily on the technical aspects of bariatric surgery. This year's event heralded a refreshing change — placing the spotlight squarely on the lived experiences of patients.
Key Themes from the 2024 Conference
New Medications Expanding the Treatment Toolkit
The past few years have witnessed the emergence of groundbreaking medications that have shown promising outcomes in weight management. These pharmaceutical advancements have effectively bridged the gap between lifestyle interventions and surgical options, offering patients a wider array of treatment choices. This expanded toolkit allows healthcare providers to tailor interventions more precisely to individual patient needs and preferences.
The Obesity Classification Debate
A particularly noteworthy development was the ongoing debate surrounding the classification of obesity itself. The conference delved into the nuanced discussion of whether obesity should be considered a risk factor or a disease — with implications that extend far beyond medical semantics into the realms of personal health and health economics.
The consensus emerging from these discussions suggests that obesity may indeed be both a risk factor and a disease, varying from individual to individual. This complex issue was set to be further explored in an upcoming publication in The Lancet.
The Voice of Patients with Lived Experience
Perhaps the most striking aspect of the 2024 conference was the amplified voice of patients with lived experience. The powerful testimonies of individuals including Mr Damien Verner (Bariatric Support Australia) and Mr Andrew Wilson (Weight Issues Network) resonated deeply with the assembled healthcare professionals, serving as a poignant reminder of the human element at the core of obesity management.
Their stories underscored the importance of creating safe, stigma-free environments where patients can access high-quality, individualised care — a principle that sits at the heart of everything we do at MedSurg Weight Loss.
The Key Takeaway: The Patient Must Be Central
While the intricacies of medical, surgical, and allied health interventions remain crucial, the patient must be at the centre of our focus. The field of obesity management is evolving towards a more holistic, patient-centric approach — recognising that treatment should be fluid and adaptable to the changing needs and circumstances of each individual.
The multifaceted nature of obesity management demands a multidisciplinary approach, with each aspect of care delivered by experts working collaboratively as part of a cohesive team. This is precisely the model we have built at MedSurg Weight Loss — and one that this conference reaffirmed as the right direction for the field.
As we move forward, it is imperative that we continue to listen to our patients, advocate for their needs, and provide premium quality care to all those living with overweight and obesity — particularly those experiencing related metabolic diseases.